SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the release of the first ...

Data in Twenty-One Poster and Oral Presentations Highlight use of GeoMx Digital Spatial Profiler and the Spatial Molecular Imager Platform for Discovery and Translational Applications During the 2021 ...

NanoString Technologies, Inc. NSTG recently made significant strides in its translational research business. The company entered into CosMxSpatial Molecular Imager partnerships with three specialty ...

RNA expression from almost 1,000 genes mapped at single cell and subcellular resolution within non-small cell lung cancer samples SEATTLE, November 09, 2021--(BUSINESS WIRE)--NanoString Technologies, ...

NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial availability of the CosMx™ Human 6K ...

NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, and Abcam (AIM: ABC; NASDAQ: ABCM), a global life science company ...

NanoString Technologies, joined by three of its subsidiaries, have filed for protection from creditors under Chapter 11 of the U.S. Bankruptcy Code, blaming the $31 million jury award assessed against ...

Major milestone marked by first public dataset released for CosMx Whole Transcriptome Panel with additional data forthcoming at the AGBT Meeting NanoString is marking this milestone achievement with ...

Major milestone marked by first public dataset released for CosMx Whole Transcriptome Panel with additional data forthcoming at the AGBT Meeting SEATTLE, January 07, 2024--(BUSINESS WIRE)--NanoString ...

Major milestone marked by first public dataset released for CosMx Whole Transcriptome Panel with additional data forthcoming at the AGBT Meeting NanoString Technologies, Inc. (NASDAQ: NSTG), a leading ...